FDA Inspection 812204 — Janssen Research & Development, LLC

Janssen Research & Development, LLC — FEI 3009708653

The FDA completed an inspection of Janssen Research & Development, LLC on Dec 19, 2012 in Titusville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 19, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Titusville, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.